Preud'Homme J L, Morel-Maroger L, Brouet J C, Mihaesco E, Mery J P, Seligmann M
Clin Exp Immunol. 1980 Dec;42(3):545-53.
In a patient treated for IgA kappa myeloma, bone marrow relapse and a sharp drop in the serum IgA level paralleled tissue deposition of non-amyloid material reactive with anti-kappa anti-alpha sera in immunofluorescence studies of kidney and liver biopsies. Clinical manifestations were progressive renal failure with nephrotic syndrome, with both tubular and glomerular lesions (including nodular glomerulosclerosis), hepatomegaly, cardiac and neurological symptoms. Biosynthesis experiments showed the production of alpha chains diminished in length by about one domain which were rapidly degraded predominantly after secretion and of two species of light chains; normal-sized light chains which assembled with alpha chains and abnormally short ones which were secreted as free light chains. The apparent molecular weight of the light chains was larger in secretions than in cytoplasmic extracts, suggesting their glycosylation. These results suggest a causal relationship between tissue deposition and production of abnormal immunoglobulins by a variant clone, the emergence of which was possibly induced by Melphalan therapy.
在一名接受治疗的IgA κ型骨髓瘤患者中,骨髓复发以及血清IgA水平急剧下降,同时在肾脏和肝脏活检的免疫荧光研究中,与抗κ抗α血清反应的非淀粉样物质在组织中沉积。临床表现为伴有肾病综合征的进行性肾衰竭,同时存在肾小管和肾小球病变(包括结节性肾小球硬化)、肝肿大、心脏和神经症状。生物合成实验表明,产生的α链长度减少了约一个结构域,这些α链在分泌后主要迅速降解,同时还产生了两种轻链;一种是与α链组装的正常大小的轻链,另一种是作为游离轻链分泌的异常短的轻链。轻链在分泌物中的表观分子量比在细胞质提取物中更大,提示其发生了糖基化。这些结果表明组织沉积与变异克隆产生异常免疫球蛋白之间存在因果关系,变异克隆的出现可能是由美法仑治疗诱导的。